Progression of Lung Disease in Preschool Patients with Cystic Fibrosis
- 1 May 2017
- journal article
- research article
- Published by Oxford University Press (OUP) in American Journal of Respiratory and Critical Care Medicine
- Vol. 195 (9) , 1216-1225
Abstract
Rationale: Implementation of intervention strategies to prevent lung damage in early cystic fibrosis (CF) requires objective outcome measures that capture and track lung disease. Objectives: To define the utility of the Lung Clearance Index (LCI), measured by multiple breath washout, as a means to track disease progression in preschool children with CF. Methods: Children with CF between the ages of 2.5 and 6 years with a confirmed diagnosis of CF and age-matched healthy control subjects were enrolled at three North American CF centers. Multiple breath washout tests were performed at baseline, 1, 3, 6, and 12 months to mimic time points chosen in clinical care and interventional trials; spirometry was also conducted. A generalized linear mixed-effects model was used to distinguish LCI changes associated with normal growth and development (i.e., healthy children) from the progression of CF lung disease. Measurements and Main Results: Data were collected on 156 participants with 800 LCI measurements. Although both LCI and spirometry discriminated health from disease, only the LCI identified significant deterioration of lung function in CF over time. The LCI worsened during cough episodes and pulmonary exacerbations, whereas similar symptoms in healthy children were not associated with increased LCI values. Conclusions: LCI is a useful marker to track early disease progression and may serve as a tool to guide therapies in young patients with CF.Keywords
This publication has 27 references indexed in Scilit:
- Changing thresholds and incidence of antibiotic treatment of cystic fibrosis pulmonary exacerbations, 1995–2005Journal of Cystic Fibrosis, 2013
- Prevalence of cystic fibrosis pathogens in the oropharynx of healthy children and implications for cystic fibrosis careJournal of Cystic Fibrosis, 2012
- Oral, inhaled, and intravenous antibiotic choice for treating pulmonary exacerbations in cystic fibrosisPediatric Pulmonology, 2012
- Effect of pulmonary exacerbations on long-term lung function decline in cystic fibrosisEuropean Respiratory Journal, 2011
- Long-term course of lung clearance index between infancy and school-age in cystic fibrosis subjectsJournal of Cystic Fibrosis, 2011
- Lung Clearance Index at 4 Years Predicts Subsequent Lung Function in Children with Cystic FibrosisAmerican Journal of Respiratory and Critical Care Medicine, 2011
- Lung Disease at Diagnosis in Infants with Cystic Fibrosis Detected by Newborn ScreeningAmerican Journal of Respiratory and Critical Care Medicine, 2009
- Inflammation, Infection, and Pulmonary Function in Infants and Young Children with Cystic FibrosisAmerican Journal of Respiratory and Critical Care Medicine, 2002
- Bronchoalveolar Lavage Findings in Cystic Fibrosis Patients with Stable, Clinically Mild Lung Disease Suggest Ongoing Infection and InflammationAmerican Journal of Respiratory and Critical Care Medicine, 1994
- Statistics in respiratory medicine. 2. Repeatability and method comparison.Thorax, 1991